Several calls for funding have been recently opened within Horizon Europe, the European funding programme for research and innovation with a budget of €95.5 billion.


Several calls for funding have been recently opened within Horizon Europe, the European funding programme for research and innovation with a budget of €95.5 billion.

The Clinical Trials Information System (CTIS) has gone live on January 31st, 2022. CTIS is the backbone of the Clinical Trials Regulation

The Therapies Scientific Committee of the International Rare Diseases Research Consortium is establishing a Task Force to characterize specific commonalities amongst a large group of “disregarded” rare diseases

IRDiRC’s Therapies Scientific Committee is establishing a Task Force on Drug Repurposing Guidebook aimed at helping developers identify specific tools and practices of relevance for repurposing projects

EMA has recently published a quick and useful guidance on different aspects related to the Advanced Therapy Medicinal Products

The International Rare Diseases Research Consortium (IRDiRC) is proud to announce the publication of a commentary on 10 years of progress and challenges of IRDiRC in the prestigious journal Nature Reviews Drug Discovery.

The European Commission, the Heads of Medicines Agencies and the European Medicines Agency have recently launched an initiative, Accelerating Clinical Trials in the European Union, to transform how clinical trials are initiated, designed and run

The Committee for Medicinal Products for Human Use at the EMA adopted a positive opinion recommending marketing authorization for Oxbryta® (voxelotor) for the treatment of haemolytic anaemia due to sickle cell disease in patients 12 years of age and older

The webinar “A magnifying glass in the world of the medical device development”, organised within the European Paediatric Translational Research Infrastructure – EPTRI, will be held on January 20th, 2022 at 11.00 CET and it will be focused on the medical device development.

A new Frontiers Research Topic is now open and it is dedicated to Real World Data generated for regulatory purposes in the rare diseases setting
Recent posts in News